This is the first study to directly associate Mfn2-mediated MAM abnormalities with hippocampal synaptic plasticity injury in diabetic mice and to delineate the synergistic promotion of mitochondrial Ca2+ overload and ERS in this process, representing a novel target for diabetes-related cognitive impairment. Here, MFN2 is linked to Cognitive impairment.